A detailed history of Kovack Advisors, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Kovack Advisors, Inc. holds 1,602 shares of AMGN stock, worth $423,712. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,602
Previous 2,154 25.63%
Holding current value
$423,712
Previous $673,000 23.33%
% of portfolio
0.06%
Previous 0.08%

Shares

39 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$309.38 - $337.38 $170,777 - $186,233
-552 Reduced 25.63%
1,602 $516,000
Q2 2024

Aug 02, 2024

SELL
$262.75 - $319.31 $404,635 - $491,737
-1,540 Reduced 41.69%
2,154 $673,000
Q1 2024

Apr 19, 2024

BUY
$268.87 - $324.56 $191,166 - $230,762
711 Added 23.84%
3,694 $1.05 Million
Q4 2023

Feb 02, 2024

BUY
$255.7 - $288.46 $36,053 - $40,672
141 Added 4.96%
2,983 $859,000
Q3 2023

Oct 19, 2023

SELL
$218.65 - $271.46 $36,514 - $45,333
-167 Reduced 5.55%
2,842 $763,000
Q2 2023

Jul 21, 2023

SELL
$214.27 - $253.37 $200,985 - $237,661
-938 Reduced 23.76%
3,009 $668,000
Q1 2023

Apr 20, 2023

BUY
$225.79 - $275.2 $110,185 - $134,297
488 Added 14.11%
3,947 $954,000
Q4 2022

Feb 22, 2023

SELL
$229.03 - $291.01 $60,463 - $76,826
-264 Reduced 7.09%
3,459 $908,000
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $248,252 - $279,983
-1,106 Reduced 22.9%
3,723 $839,000
Q2 2022

Aug 10, 2022

BUY
$230.71 - $256.74 $211,330 - $235,173
916 Added 23.41%
4,829 $1.18 Million
Q1 2022

May 16, 2022

BUY
$219.27 - $242.57 $280,884 - $310,732
1,281 Added 48.67%
3,913 $946,000
Q4 2021

Jan 18, 2022

SELL
$198.88 - $227.6 $22,473 - $25,718
-113 Reduced 4.12%
2,632 $592,000
Q3 2021

Nov 03, 2021

SELL
$212.27 - $248.7 $3,184 - $3,730
-15 Reduced 0.54%
2,745 $584,000
Q2 2021

Jul 29, 2021

SELL
$233.58 - $259.14 $3,503 - $3,887
-15 Reduced 0.54%
2,760 $673,000
Q1 2021

May 04, 2021

BUY
$221.91 - $258.6 $17,752 - $20,688
80 Added 2.97%
2,775 $690,000
Q4 2020

Jan 14, 2021

BUY
$216.38 - $257.67 $4,976 - $5,926
23 Added 0.86%
2,695 $620,000
Q3 2020

Nov 02, 2020

BUY
$234.65 - $260.95 $34,493 - $38,359
147 Added 5.82%
2,672 $679,000
Q2 2020

Jul 31, 2020

SELL
$197.81 - $242.74 $27,891 - $34,226
-141 Reduced 5.29%
2,525 $596,000
Q1 2020

Apr 30, 2020

BUY
$182.24 - $241.7 $485,851 - $644,372
2,666 New
2,666 $541,000
Q4 2019

Jan 29, 2020

SELL
$189.21 - $243.2 $665,073 - $854,848
-3,515 Closed
0 $0
Q3 2019

Oct 31, 2019

SELL
$174.11 - $208.62 $37,259 - $44,644
-214 Reduced 5.74%
3,515 $680,000
Q2 2019

Aug 14, 2019

SELL
$166.7 - $195.41 $195,205 - $228,825
-1,171 Reduced 23.9%
3,729 $687,000
Q1 2019

May 03, 2019

SELL
$180.87 - $203.88 $234,226 - $264,024
-1,295 Reduced 20.9%
4,900 $931,000
Q4 2018

Feb 06, 2019

BUY
$178.4 - $208.25 $274,022 - $319,872
1,536 Added 32.97%
6,195 $1.21 Million
Q3 2018

Oct 09, 2018

BUY
$185.29 - $208.89 $51,695 - $58,280
279 Added 6.37%
4,659 $966,000
Q2 2018

Aug 01, 2018

SELL
$166.05 - $186.51 $294,572 - $330,868
-1,774 Reduced 28.83%
4,380 $808,000
Q1 2018

May 15, 2018

SELL
$169.43 - $198.0 $23,381 - $27,324
-138 Reduced 2.19%
6,154 $1.05 Million
Q4 2017

May 15, 2018

SELL
$168.79 - $188.59 $46,079 - $51,485
-273 Reduced 4.16%
6,292 $1.09 Million
Q4 2017

Feb 01, 2018

BUY
$168.79 - $188.59 $2,363 - $2,640
14 Added 0.21%
6,565 $1.14 Million
Q3 2017

Aug 02, 2018

BUY
$167.29 - $191.0 $38,978 - $44,503
233 Added 3.69%
6,551 $1.22 Million
Q2 2017

Aug 30, 2018

BUY
N/A
1,985 Added 45.81%
6,318 $1.09 Million
Q1 2017

Sep 05, 2018

BUY
N/A
161 Added 3.86%
4,333 $711,000
Q4 2016

Sep 10, 2018

BUY
N/A
329 Added 8.56%
4,172 $610,000
Q3 2016

Sep 25, 2018

BUY
N/A
88 Added 2.34%
3,843 $641,000
Q2 2016

Oct 01, 2018

SELL
N/A
-2,309 Reduced 38.08%
3,755 $571,000
Q1 2016

Oct 12, 2018

BUY
N/A
2,227 Added 58.04%
6,064 $909,000
Q4 2015

Oct 18, 2018

BUY
N/A
111 Added 2.98%
3,837 $623,000
Q3 2015

Oct 29, 2018

BUY
N/A
1,843 Added 97.88%
3,726 $515,000
Q2 2015

Nov 06, 2018

BUY
N/A
1,883
1,883 $289,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Kovack Advisors, Inc. Portfolio

Follow Kovack Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kovack Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kovack Advisors, Inc. with notifications on news.